Federal Register / Vol. 66, No. 244 / Wednesday, December 19, 2001 / Notices 65505

Type of Request: New. The Health

Resources and Services Administration

previously administered this program.

Use: Consistent with 45 CFR part 74,

subpart J, the AoA requires grantees

funded under Alzheimer’s Disease

Demonstration Grants to States Program

(ADDGS) to report on the performance

of their projects. The report is used by

the AoA to review and monitor the

grantee’s progress in achieving project

objectives, to provide advice and

assistance, and to take corrective action

as necessary.

Frequency: Semiannual.

Respondent: Alzheimer’s Disease

Demonstration Grants to States Program

grantees.

Estimated number of respondents: 25.

Estimated burden hours: 1,000 per

year (20 hours for each semiannual

report).

Additional Information: Each progress

report, typically no more than 10 pages

in length, is expected to cover the

following subjects: recent major

activities and accomplishments,

obstacles encountered and solutions,

significant findings and events,

dissemination activities, and activities

planned for the next 6 months. Only

states who have voluntarily applied for

and been awarded a grant under the

Alzheimer’s Demonstration Program are

required to submit these reports.

OMB Comment: A comment is best

assured of having its full effect if OMB

receives it as soon as possible after its

publication. Written comments and

recommendations for the proposed

information collection should be sent to

the following address within 30 days of

the publication of this notice: Office of

Information and Regulatory Affairs,

Attention: Allison Herron Eydt, AoA

Desk Officer, Office of Management and

Budget, Washington, DC 20503.

Dated: November 27, 2001.

Josefina G. Carbonell,

Assistant Secretary for Aging.

[FR Doc. 01–31206 Filed 12–18–01; 8:45 am]

BILLING CODE 4154–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 02019]

Cooperative Agreement for the

Surveillance, Research, and

Prevention of Birth Defects; Notice of

Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2002

funds for a cooperative agreement

program for the surveillance, research,

and prevention of birth defects. The

purpose of this program is to aid in the

surveillance, research, and prevention

of birth defects.

B. Eligible Applicants

Assistance will be provided only to

the International Centre for Birth

Defects (ICBD). No other applications

are solicited.

Located in Rome, Italy, ICBD was

established in 1989 as an organization

devoted to the prevention of birth

defects through surveillance, training,

and epidemiologic research. ICBD

accomplishes this by serving as the

headquarters for the International

Clearinghouse for Birth Defects

Monitoring Programs. The

Clearinghouse is a non-governmental

organization comprised of 32 member

programs representing 34 countries in

Europe, the Americas, Japan, China,

South Africa, and Australia. The

Clearinghouse’s mission is to prevent

birth defects through the exchange of

information, enabling collaborative

research, and consultation and

assistance. Specifically, the

Clearinghouse:

1. Responds to possible or suspected

clusters of congenital malformations

with information, monitoring systems,

and personnel so that member countries

are alerted and preventive action may be

taken. This is the primary and most

enduring goal of the Clearinghouse;

2. Enables collaborative

epidemiological research based on birth

defect surveillance data obtained from

the member programs. Joint studies with

the member programs have attempted to

provide an understanding of endemic

occurrence as well as temporal and/or

geographical clusters of malformations;

and

3. Provides expert consultation and

assistance.

Note: Title 2 of the United States Code,

section 1611 states that an organization

described in section 501(c)(4) of the Internal

Revenue Code that engages in lobbying

activities is not eligible to receive Federal

funds constituting an award, grant, or loan.

C. Availability of Funds

Approximately $150,000 is available

in FY 2002 to fund this award. It is

expected that the award will begin on or

about April 1, 2002, and will be made

for a 12-month budget period within a

project period of up to three years.

Funding estimates may change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

Use of Funds

Funds may be utilized only for the

purpose and for the activities described

and approved in the final award.

1. All requests for funds contained in

the budget shall be stated in U.S.

dollars. Once an award is made, CDC

will not compensate foreign grantees for

currency exchange fluctuations through

the issuance of supplemental awards.

a. Funds may be spent for reasonable

program purposes, including personnel,

travel, supplies, and services.

Equipment may be purchased if deemed

necessary to accomplish program

objectives, however, prior approval by

CDC officials must be requested in

writing.

b. The costs that are generally

allowable in grants to domestic

organizations are allowable to foreign

institutions and international

organizations, with the following

exception: Indirect costs will not be

paid (either directly or through subaward) to organizations located outside

the territorial limits of the United States

or to international organizations

regardless of their location.

c. The applicant may contract with

other organizations under this program.

However, the applicant must perform a

substantial portion of the activities

including program management and

operations, and delivery of prevention

services for which funds are required.

D. Where To Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address http://www.cdc.gov.

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To obtain business management

technical assistance, contact: Angelia D.

Hill, Grants Management Specialist,

International Grants and Contracts

Branch, Procurement and Grants Office,

Centers for Disease Control and

65506 Federal Register / Vol. 66, No. 244 / Wednesday, December 19, 2001 / Notices

Prevention (CDC), 2920 Brandywine

Road, Room 3000, Atlanta, GA 30341–

4146, Telephone: (770) 488–2785, Email address: aph8@cdc.gov.

Program technical assistance may be

obtained from: J. David Erickson,

National Center on Birth Defects and

Developmental Disabilities, Centers for

Disease Control and Prevention (CDC),

4770 Buford Highway NE., Atlanta, GA

30341–3724, Telephone: (770) 488–

7161, E-mail address: jde1@cdc.gov.

Dated: December 12, 2001.

Rebecca B. O’Kelley,

Chief, International Grants and Contracts

Branch, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–31222 Filed 12–18–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Childhood

Lead Poisoning Prevention; Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC) announces the

following committee meeting.

Name: Advisory Committee on Childhood

Lead Poisoning Prevention.

Times and Dates:

8:30 a.m.–5:45 p.m., January 15, 2002,

8:30 a.m.–12:15 p.m., January 16, 2002.

Place: Hilton Crystal City Hotel, 2399

Jefferson Davis Highway, Arlington, VA

22202, telephone 703/418–6800.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 90 people.

Purpose: The Committee shall provide

advice and guidance to the Secretary; the

Assistant Secretary for Health; and the

Director, CDC, regarding new scientific

knowledge and technological developments

and their practical implications for

childhood lead poisoning prevention efforts.

The Committee shall also review and report

regularly on childhood lead poisoning

prevention practices and recommend

improvements in national childhood lead

poisoning prevention efforts.

Matters to be Discussed: Agenda items

include: Updates on Primary Prevention

issues, Medicaid Targeted Screening issues,

Case Management issues, MMWR Publication

Process, Presentations on Milwaukee’s

Community-Based Environmental

Intervention Strategies, National Survey of

Lead and Allergens in Housing, and

Discussion of Charge for Workgroup

Reviewing Evidence of Adverse Effects of

Lead. Agenda items are subject to change as

priorities dictate.

Opportunities will be provided during the

meeting for oral comments. Depending on the

time available and the number of requests, it

may be necessary to limit the time of each

presenter.

Contact Person for More Information:

Becky Wright, Program Analyst, Lead

Poisoning Prevention Branch, Division of

Environmental Hazards and Health Effects,

NCEH, CDC, 1600 Clifton Road, NE, M/S E–

25, Atlanta, Georgia 30333, telephone 404/

498–1449, fax 404/498–1444.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: December 10, 2001.

John Burckhardt,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention.

[FR Doc. 01–31221 Filed 12–18–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Medicare & Medicaid

Services

Notice of Hearing: Reconsideration of

Disapproval of Missouri State Plan

Amendment (SPA) 92–33

AGENCY: Centers for Medicare &

Medicaid Services (CMS), HHS.

ACTION: Notice of hearing.

SUMMARY: This notice announces an

administrative hearing to reconsider the

decision to disapprove Missouri SPA

92–33 on January 23, 2002, at 10 a.m.,

Richard Bolling Federal Building; Plaza

Room 664; 601 East Twelfth Street;

Kansas City, Missouri 64106–2808.

CLOSING DATES: Requests to participate

in the hearing as a party must be

received by the presiding officer by

January 3, 2002.

FOR FURTHER INFORMATION CONTACT:

Kathleen Scully-Hayes, Office of

Hearings, Centers for Medicare &

Medicaid Services, Suite L 2520 Lord

Baltimore Drive, Baltimore, Maryland

21244–2670, Telephone: (410) 786–

2055.

SUPPLEMENTARY INFORMATION: This

notice announces an administrative

hearing to reconsider our decision to

disapprove Missouri SPA 92–33.

Section 1116 of the Social Security

Act (the Act) and 42 CFR part 430

establish HHS procedures that provide

an administrative hearing for

reconsideration of a disapproval of a

State plan or plan amendment. The

Centers for Medicare & Medicaid

Services (CMS) is required to publish a

copy of the notice to a state Medicaid

agency that informs the agency of the

time and place of the hearing and the

issues to be considered. If we

subsequently notify the agency of

additional issues that will be considered

at the hearing, we will also publish that

notice. Any individual or group that

wants to participate in the hearing as a

party must petition the presiding officer

within 15 days after publication of this

notice, in accordance with the

requirements contained at 42 CFR

430.76(b)(2). Any interested person or

organization that wants to participate as

amicus curiae must petition the

presiding officer before the hearing

begins in accordance with the

requirements contained at 42 CFR

430.76(c). If the hearing is later

rescheduled, the presiding officer will

notify all participants.

The issue is whether the provisions of

section 1923(f)(1)(A) of the Act and

regulations at 42 CFR 447.296(b)(6)

would permit the State to increase

disproportionate share hospital (DSH)

payments under this State plan

amendment submitted after September

30, 1991. Missouri submitted SPA 92–

33 on November 18, 1991, as part of

SPA 91–50. This amendment would

provide for an additional payment to 10

DSH hospitals that have the highest

Medicaid utilization in the State and

had a high volume of nursery and

neonatal care days.

Under the Medicaid Voluntary

Contribution and Provider Specific Tax

Amendments of 1991 (Pub. L. 102–234),

which added section 1923(f)(l)(A) of the

Act and the Federal regulation at 42

CFR 447.296(b)(6), the State cannot

increase DSH payments to hospitals

based on amendments submitted after

September 30, 1991, for payments made

during the period January 1, 1992,

through September 30, 1992, except in

very limited circumstances. The reason

for this moratorium on DSH payments

was so CMS could determine a state’s

base DSH allotments for an annual

period beginning in Federal fiscal year

1993.

The additional DSH payment

included in this amendment is not

within the statutory exception for

payments under certain SPAs submitted

to the Secretary between September 30,

1991, and November 26, 1991. This

exception applies only to an

amendment that designates only DSHs

with a Medicaid or low-income

utilization percentage at or above the

statewide arithmetic mean. In